Published in Int J Dermatol on July 01, 2006
Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci (2007) 1.50
CD1a on Langerhans cells controls inflammatory skin disease. Nat Immunol (2016) 1.48
Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis (2001) 2.39
Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. J Invest Dermatol (1998) 2.37
Basal cell carcinoma. BMJ (2003) 2.10
The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol (2000) 1.69
Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant (2008) 1.65
Skin disorders in amputees. J Am Acad Dermatol (2000) 1.65
Dermatological manifestations of Down's syndrome. Clin Exp Dermatol (2006) 1.57
Adult coeliac disease, dermatitis herpetiformis and smoking. Gut (1997) 1.50
Infliximab as a treatment for recalcitrant pyoderma gangrenosum. Clin Exp Dermatol (2004) 1.45
An audit to identify the optimum referral rate to a contact dermatitis investigation unit. Br J Dermatol (1999) 1.38
Secondary syphilis with framboesiform facial lesions: a case report. Br J Vener Dis (1981) 1.24
Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res (2000) 1.18
Susceptibility to basal cell carcinoma: associations with PTCH polymorphisms. Ann Hum Genet (2004) 1.17
Extensive nevus comedonicus. Arch Dermatol (1980) 1.16
Surveillance of occupational skin disease: EPIDERM and OPRA. Br J Dermatol (2000) 1.15
Occupational contact dermatitis in the UK: a surveillance report from EPIDERM and OPRA. Occup Med (Lond) (2000) 1.15
Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol (2000) 1.13
Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res (1996) 1.06
Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci. Carcinogenesis (1999) 1.06
Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatolog Treat (2001) 1.03
Type I allergic reaction to hyaluronidase during ophthalmic surgery. Contact Dermatitis (2001) 0.99
Pili annulati coincident with alopecia areata. Pediatr Dermatol (1998) 0.98
Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem Biol Interact (1998) 0.98
Allergic contact dermatitis to epichlorhydrin in a solvent cement. Contact Dermatitis (1983) 0.96
Genetics and risk factors for basal cell carcinoma. Br J Dermatol (2006) 0.95
Basal cell carcinoma and risk of subsequent malignancies: A cancer registry-based study in southwest England. J Am Acad Dermatol (2000) 0.95
Progesterone-induced urticaria--need it be autoimmune? Br J Dermatol (1995) 0.93
Glutathione S-transferase GSTP1 and cyclin D1 genotypes: association with numbers of basal cell carcinomas in a patient subgroup at high-risk of multiple tumours. Pharmacogenetics (2000) 0.92
Phaeohyphomycosis caused by Exophiala salmonis. Br J Dermatol (2006) 0.92
Patch testing to detect corticosteroid allergy: is it adequate? Contact Dermatitis (1997) 0.91
Screening for corticosteroid contact hypersensitivity. Contact Dermatitis (1995) 0.91
Azathioprine in dermatology: a survey of current practice in the U.K. Br J Dermatol (1997) 0.90
Sequential treatment of giant basal cell carcinomas. J Plast Reconstr Aesthet Surg (2008) 0.90
Utilities for advanced basal cell carcinoma. J Med Econ (2013) 0.90
Contact hypersensitivity to monobenzyl ether of hydroquinone used to treat vitiligo. Contact Dermatitis (1998) 0.86
Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype. Pharmacogenetics (2001) 0.86
Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomas. Br J Dermatol (2000) 0.86
Acne vulgaris and hidradenitis suppurativa as presenting features of acromegaly. Br Med J (Clin Res Ed) (1983) 0.84
Allergic contact dermatitis from Machaerium scleroxylum Tul. (Pao ferro) in a joinery shop. Clin Exp Dermatol (1984) 0.84
Anaphylaxis after hepatitis B vaccination. Lancet (1995) 0.83
Ammonium persulphate sensitivity in hairdressers. Contact Dermatitis (1985) 0.83
British Association of Dermatologists' guidelines for the management of onychomycosis 2014. Br J Dermatol (2014) 0.83
Anaphylaxis to intradermal triamcinolone acetonide. Arch Dermatol (1998) 0.83
Angiolymphoid hyperplasia with eosinophilia affecting the penis. Br J Dermatol (2008) 0.83
Corticosteroid contact hypersensitivity: what vehicle and concentration? Contact Dermatitis (1996) 0.82
Cytochrome P450 CYP2D6 genotypes: association with hair colour, Breslow thickness and melanocyte stimulating hormone receptor alleles in patients with malignant melanoma. Pharmacogenetics (1999) 0.82
Allergic contact dermatitis from latex rubber. Br J Dermatol (1996) 0.82
Allergic contact dermatitis from an anthraquinone derivative in a chemical plant. Contact Dermatitis (1994) 0.81
Occupational allergic contact dermatitis from triphenyl phosphite. Contact Dermatitis (1989) 0.81
Occupational skin infections. Occup Med (Lond) (2004) 0.81
Epidemiological survey of standard series patch test results and observations on day 2 and day 4 readings. Contact Dermatitis (1991) 0.81
Basal cell carcinoma. Cancer (2000) 0.81
Spa pool dermatitis. Contact Dermatitis (1995) 0.81
Bullous pemphigoid following influenza vaccination. Clin Exp Dermatol (1996) 0.80
Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype. Cancer Epidemiol Biomarkers Prev (1999) 0.80
Polymorphism in glutathione S-transferase loci as a risk factor for common cancers. Arch Toxicol Suppl (1998) 0.80
Incidence by occupation and industry of work-related skin diseases in the United Kingdom, 1996-2001. Occup Med (Lond) (2006) 0.80
Does influenza vaccination induce bullous pemphigoid? A report of four cases. Br J Dermatol (1998) 0.80
Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy. J Eur Acad Dermatol Venereol (2013) 0.80
Contact dermatitis from 2-n-octyl-4-isothiazolin-3-one in a PhD student. Contact Dermatitis (2004) 0.80
Severe erythema multiforme complicated by fatal gastrointestinal involvement following co-trimoxazole therapy. Clin Exp Dermatol (1979) 0.80
Allergic contact dermatitis to crystal violet lactone [corrected] in carbonless copy paper. Contact Dermatitis (1987) 0.80
Eruptive collagenomas of the skin: a case history. Pediatr Dermatol (1998) 0.79
Intolerance and contact allergy to tar and dithranol in psoriasis. Contact Dermatitis (1994) 0.79
Epidermoid cysts mimicking recurrence of superficial basal cell carcinoma following photodynamic therapy. Clin Exp Dermatol (2006) 0.79
Scytalidium hyalinum onychomycosis successfully treated with 5% amorolfine nail lacquer. Br J Dermatol (1999) 0.79
The significance of positive patch tests to 17-hydroxyprogesterone. Contact Dermatitis (1994) 0.78
Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone. Clin Exp Dermatol (1997) 0.78
Lymphocyte transformation and thiuram sensitization. Contact Dermatitis (1991) 0.78
Contact sensitivity to octyldodecanol and trometamol in an anti-itch cream. Contact Dermatitis (2007) 0.78
The incidence of occupational skin disease as reported to The Health and Occupation Reporting (THOR) network between 2002 and 2005. Br J Dermatol (2007) 0.78
Contact sensitivity to vanilla in a lip salve. Contact Dermatitis (1995) 0.78
Erythema nodosum and circulating immune complexes in acne fulminans after treatment with isotretinoin. Br Med J (Clin Res Ed) (1985) 0.78
Patients with truncal basal cell carcinoma represent a high-risk group. Arch Dermatol (1998) 0.78
Type IV hypersensitivity reactions to natural rubber latex: results of a multicentre study. Br J Dermatol (2002) 0.78
Photodynamic therapy for actinic keratosis in organ transplant patients. J Eur Acad Dermatol Venereol (2011) 0.77
Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group. Br J Dermatol (2006) 0.77
Occupational allergic contact dermatitis due to 3-dimethylaminopropylamine. Contact Dermatitis (1993) 0.77
Cold urticaria responding to systemic ciclosporin. Br J Dermatol (2003) 0.77
Latex contact urticaria presenting as facial swelling in a motor mechanic. Contact Dermatitis (1997) 0.77
Sporotrichoid streptococcal pyoderma. J Eur Acad Dermatol Venereol (2007) 0.77
The prevalence of corticosteroid allergy in two U.K. centres: prescribing implications. Br J Dermatol (1999) 0.77
Contact allergy to musk moskene in a perfumed moisturizing cream. Contact Dermatitis (1997) 0.77
Adverse cutaneous reactions to cosmetic allergens. Contact Dermatitis (1999) 0.77
Acne in a Becker's naevus: an androgen-mediated link? Clin Exp Dermatol (1998) 0.77
Allergic contact dermatitis from primula presenting as vitiligo. Contact Dermatitis (1999) 0.77
Contact allergy to oak moss resin in a soluble oil. Contact Dermatitis (2000) 0.77
Pyoderma gangrenosum in a thoracotomy wound associated with a pulmonary cavitating lesion. Clin Exp Dermatol (2003) 0.76
Azathioprine: clinical pharmacology and current indications in autoimmune disorders. BioDrugs (1998) 0.76
Bullous pyoderma gangrenosum, Sweet's syndrome and malignancy. Br J Dermatol (1997) 0.76
Basal cell carcinoma follow-up practices by dermatologists: a national survey. Br J Dermatol (2001) 0.76
An outbreak of furniture related dermatitis ('sofa dermatitis') in Finland and the UK: history and clinical cases. J Eur Acad Dermatol Venereol (2009) 0.76
Peristomal dermatoses: a novel indication for topical steroid lotions. J Am Acad Dermatol (2000) 0.76
Highly active antiretroviral therapy-induced regression of basal cell carcinomas in a patient with acquired immunodeficiency and Gorlin syndrome. Br J Dermatol (2006) 0.76
Systemic treatments for basal cell carcinoma (BCC): the advent of dermato-oncology in BCC. Br J Dermatol (2013) 0.76
Postinflammatory hyperpigmentation in an Asian patient: a dramatic response to oral isotretinoin (13-cis-retinoic acid). Br J Dermatol (2005) 0.76
Efficacy of photodynamic therapy for treatment of basal cell carcinoma in organ transplant recipients. Lasers Med Sci (2013) 0.76
Contact hypersensitivity to topical corticosteroids. Br J Dermatol (1992) 0.76
Allergic contact dermatitis from tea tree oil in a wart paint. Contact Dermatitis (1997) 0.75
Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up. Br J Dermatol (2006) 0.75